Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

Nature volume 506, pages 445–450 (2014)Cite this article

Subjects

Abstract

Ependymomas are common childhood brain tumours that occur throughout the nervous system, but are most common in the paediatric hindbrain. Current standard therapy comprises surgery and radiation, but not cytotoxic chemotherapy as it does not further increase survival. Whole-genome and whole-exome sequencing of 47 hindbrain ependymomas reveals an extremely low mutation rate, and zero significant recurrent somatic single nucleotide variants. Although devoid of recurrent single nucleotide variants and focal copy number aberrations, poor-prognosis hindbrain ependymomas exhibit a CpG island methylator phenotype. Transcriptional silencing driven by CpG methylation converges exclusively on targets of the Polycomb repressive complex 2 which represses expression of differentiation genes through trimethylation of H3K27. CpG island methylator phenotype-positive hindbrain ependymomas are responsive to clinical drugs that target either DNA or H3K27 methylation both in vitro and in vivo. We conclude that epigenetic modifiers are the first rational therapeutic candidates for this deadly malignancy, which is epigenetically deregulated but genetically bland.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Somatic SNVs are rare in the posterior fossa ependymoma genome.
Figure 2: DNA-methylation profiles suggest that group A ependymomas demonstrate a CpG island methylator phenotype.
Figure 3: Group A (CIMP+) and group B (CIMP−) ependymomas are distinguished by CpG-hypermethylated and H3K27-trimethylated genes related to PRC2 occupancy in ES cells.
Figure 4: Whole-genome bisulphite sequencing validates a CpG island methylator phenotype in group A ependymoma.
Figure 5: Modulation of H3K27 methylation has anti-neoplastic effects against group A ependymoma.

Accession codes

Accessions

Gene Expression Omnibus

Data deposits

Illumina 450K CpG Methylation array data, NimbleGen 385K CpG Island Plus array data, and ChIP-seq data have been deposited at the Gene Expression Omnibus (GEO: http://www.ncbi.nlm.nih.gov/geo/) as a GEO super-series under the accession number GSE43353. Whole-genome and whole-exome sequencing data have been deposited in the European Genome-Phenome Archive (EGA: https://www.ebi.ac.uk/ega/) hosted by the EBI, under the accession number EGAS00001000443.

References

  1. Taylor, M. D. et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8, 323–335 (2005)

    Article  CAS  PubMed  Google Scholar 

  2. Merchant, T. E. et al. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 10, 258–266 (2009)

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bouffet, E. & Foreman, N. Chemotherapy for intracranial ependymomas. Childs Nerv. Syst. 15, 563–570 (1999)

    Article  CAS  PubMed  Google Scholar 

  4. Bouffet, E. et al. Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation. Int. J. Radiat. Oncol. Biol. Phys. 83, 1541–1548 (2012)

    Article  PubMed  Google Scholar 

  5. Johnson, R. A. et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466, 632–636 (2010)

    ADS  CAS  PubMed  PubMed Central  Google Scholar 

  6. Witt, H. et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20, 143–157 (2011)

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Wani, K. et al. A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol. 123, 727–738 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Atkinson, J. M. et al. An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. Cancer Cell 20, 384–399 (2011)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Jones, D. T. et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 488, 100–105 (2012)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214–218 (2013)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  11. Dees, N. D. et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 22, 1589–1598 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462–477 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Koboldt, D. C. et al. Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70 (2012)

    Article  ADS  CAS  Google Scholar 

  14. Muzny, D. M. et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012)

    Article  ADS  CAS  Google Scholar 

  15. Peifer, M. et al. Integrative genomic analyses identify key somatic driver mutations of small-cell lung cancer. Nature Genetics 44, 1104–1110 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157–163 (2012)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  17. Hammerman, P. S. et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519–525 (2012)

    Article  ADS  CAS  Google Scholar 

  18. Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251–263 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Chapman, M. A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467–472 (2011)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  20. Imielinski, M. et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107–1120 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Bell, D. et al. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609–615 (2011)

    Article  CAS  Google Scholar 

  22. Pugh, T. J. et al. The genetic landscape of high-risk neuroblastoma. Nature Genetics 45, 279–284 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214–220 (2011)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lee, R. S. et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J. Clin. Invest. 122, 2983–2988 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Zhang, J. et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 481, 329–334 (2012)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  26. Northcott, P. A. et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488, 49–56 (2012)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  27. Pugh, T. J. et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106–110 (2012)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  28. Robinson, G. et al. Novel mutations target distinct subgroups of medulloblastoma. Nature 488, 43–48 (2012)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  29. Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226–231 (2012)

    Article  ADS  CAS  PubMed  Google Scholar 

  30. Sausen, M. et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nature Genet. 45, 12–17 (2013)

    Article  CAS  PubMed  Google Scholar 

  31. Wu, G. et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nature Genet. 44, 251–253 (2012)

    Article  CAS  PubMed  Google Scholar 

  32. Versteege, I. et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203–206 (1998)

    Article  ADS  CAS  PubMed  Google Scholar 

  33. Northcott, P. A. et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nature Genet. 41, 465–472 (2009)

    Article  CAS  PubMed  Google Scholar 

  34. Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510–522 (2010)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Ohm, J. E. et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nature Genet. 39, 237–242 (2007)

    Article  CAS  PubMed  Google Scholar 

  36. Kantarjian, H. et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 106, 1794–1803 (2006)

    Article  CAS  PubMed  Google Scholar 

  37. Tan, J. et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 21, 1050–1063 (2007)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. McCabe, M. T. et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492, 108–112 (2012)

    Article  ADS  CAS  PubMed  Google Scholar 

  39. Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479–483 (2012)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  40. Williams, K. et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473, 343–348 (2011)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  41. Fang, F. et al. Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci. Transl. Med. 3, 75ra25 (2011)

    Article  PubMed  PubMed Central  Google Scholar 

  42. Roman-Gomez, J. et al. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J. Clin. Oncol. 23, 7043–7049 (2005)

    Article  CAS  PubMed  Google Scholar 

  43. Zouridis, H. et al. Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci. Transl. Med. 4, 156ra140 (2012)

    Article  PubMed  Google Scholar 

  44. Toyota, M. et al. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA 96, 8681–8686 (1999)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  45. Weisenberger, D. J. et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genet. 38, 787–793 (2006)

    Article  CAS  PubMed  Google Scholar 

  46. Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature Genet. 40, 499–507 (2008)

    Article  CAS  PubMed  Google Scholar 

  47. Down, T. A. et al. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nature Biotechnol. 26, 779–785 (2008)

    Article  CAS  Google Scholar 

  48. Lupien, M. et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958–970 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Hansen, K. D. et al. Increased methylation variation in epigenetic domains across cancer types. Nature Genet. 43, 768–775 (2011)

    Article  CAS  PubMed  Google Scholar 

  50. Gallo, M. et al. A tumorigenic MLL-homeobox network in human glioblastoma stem cells. Cancer Res. 73, 417–427 (2013)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

M.D.T. holds a Canadian Institutes of Health Research (CIHR) Clinician-Scientist Phase II Award, was a Sontag Foundation Distinguished Scholar, and is supported by The Garron Family Chair in Childhood Cancer Research. M.D.T. is supported by grants from the Cure Search Foundation, The Younger Foundation, the National Institutes of Health (R01CA148699 and R01CA159859), The Pediatric Brain Tumor Foundation, The Canadian Cancer Society, The Terry Fox Research Institute, and Brainchild. S.M., K.M.W. and A.D. are supported by Vanier Scholarships from CIHR. S.M. would like to thank K. Mack, R. Mack, S. Mack and K. Bertrand for their support of this project. This study was conducted with the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. This work was also supported by a Program Project Grant from the Terry Fox Research Institute, and a Grand Challenge Award from CureSearch for Children’s Cancer. Additionally, this work was supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants 01KU1201A, MedSys 0315416C and NGFNplus 01GS0883). This study was supported by grants from the Sander Foundation and DKTK (Molecular Diagnostics of Pediatric Malignancies). For technical support and expertise of next-generation sequencing efforts we thank the DKFZ Genomics and Proteomics Core Facility, The EMBL Genomics Core Facility, and The Centre for Applied Genomics (Toronto). We thank S. Archer for technical writing and C. Smith for artwork. We thank A. Wittmann, L. Sieber and L. Linke for clinical assistance.

Author information

Author notes

  1. S. C. Mack and H. Witt: These authors contributed equally to this work.

Authors and Affiliations

  1. Developmental & Stem Cell Biology Program, Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada,

    S. C. Mack, X. Wang, M. Gallo, L. Garzia, K. Zayne, V. Ramaswamy, D. J. H. Shih, R. Head, M. Remke, C. C. Faria, M. Barszczyk, A. M. Dubuc, J. Peacock, K. C. Bertrand, S. Agnihotri, F. M. G. Cavalli, I. Clarke, K. Nethery-Brokx, X. Wu, Y. Yao, P. Sin-Chan, J. Zuccaro, L. Lau, S. Pereira, P. Castelo-Branco, S. W. Scherer, A. Huang, U. Tabori, C. Hawkins, P. N. Kongkham, J. T. Rutka, P. B. Dirks & M. D. Taylor

  2. Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada,

    S. C. Mack, X. Wang, V. Ramaswamy, D. J. H. Shih, M. Remke, M. Barszczyk, A. M. Dubuc, J. Peacock, K. C. Bertrand, Y. Yao, C. Hawkins, P. N. Kongkham, J. T. Rutka, P. B. Dirks & M. D. Taylor

  3. Division of Neurosurgery, University of Toronto, Toronto, Ontario M5S 1A8, Canada,

    S. C. Mack, P. N. Kongkham, J. T. Rutka, P. B. Dirks & M. D. Taylor

  4. Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany,

    H. Witt, D. T. W. Jones, M. Ryzhova, S. Stark, H. Seker-Cin, S. Hutter, P. Johann, S. Bender, T. Tzaridis, P. A. Northcott, M. Kool & S. M. Pfister

  5. Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg 69120, Germany,

    H. Witt, T. Milde, A. E. Kulozik, O. Witt & S. M. Pfister

  6. German Cancer Consortium (DKTK), Heidelberg 69120, Germany,

    H. Witt, R. M. Piro, L. Gu, A. M. Stütz, N. Jäger, D. T. W. Jones, M. Sill, M. Ryzhova, T. Zichner, S. Stark, H. Seker-Cin, S. Hutter, P. Johann, S. Bender, V. Hovestadt, T. Tzaridis, P. A. Northcott, T. Milde, A. E. Kulozik, A. von Deimling, O. Witt, M. Kool, R. Eils, P. Lichter, S. M. Pfister & A. Korshunov

  7. Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,

    R. M. Piro, V. Hovestadt & P. Lichter

  8. Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,

    L. Gu, N. Jäger & R. Eils

  9. Department of Molecular Genetics, Banting and Best Department of Medical Research, The Donnelly Centre, University of Toronto, Toronto, Ontario M4N 1X8, Canada,

    S. Zuyderduyn & G. D. Bader

  10. Genome Biology, European Molecular Biology, Laboratory Meyerhofstr. 1, Heidelberg 69117, Germany,

    A. M. Stütz, T. Zichner & J. O. Korbel

  11. Department of Genetics, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, 03756, New Hampshire, USA

    X. Zhang

  12. Division of Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,

    M. Sill

  13. Department of Neurology, Harvard Medical School, Children’s Hospital Boston, MIT, Boston, Massachusetts 02115, USA,

    T. J. Pugh & S. L. Pomeroy

  14. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, 77030, Texas, USA

    K. M. Wani & K. D. Aldape

  15. Ontario Cancer Institute, Princess Margaret Cancer Centre–University Health Network, Toronto, Ontario M5G 1L7, Canada,

    S. D. Bailey & M. Lupien

  16. Ontario Institute for Cancer Research, Toronto, Ontario M5G 1L7, Canada,

    S. D. Bailey & M. Lupien

  17. Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline Pharmaceuticals, Collegeville, 19426, Pennsylvania, USA

    C. L. Creasy & S. K. Verma

  18. Department of Oncogenomics, Academic Medical Center, Amsterdam 1105, The Netherlands,

    J. Koster

  19. CCU Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,

    T. Milde & O. Witt

  20. Department of Microbiology & Immunology, Centre for High-Throughput Biology, University of British Columbia, Vancouver, V6T 1Z4 British Columbia, Canada,

    M. Hirst

  21. Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada,

    M. Hirst & M. A. Marra

  22. Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6H 3N1, Canada,

    M. A. Marra

  23. Department of Pediatrics and National Capital Consortium, Uniformed Services University, Bethesda, 20814, Maryland, USA

    S. S. Roberts

  24. Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, 84132, Utah, USA

    D. Fults

  25. Pediatric Neurosurgery, Catholic University Medical School, Gemelli Hospital, Rome 00168, Italy,

    L. Massimi

  26. Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, 94305, California, USA

    Y. J. Cho

  27. Department of Pediatrics, Virginia Commonwealth, Richmond, 23298-0646, Virginia, USA

    T. Van Meter

  28. Department of Pathology, University of Warsaw, Children’s Memorial Health Institute University of Warsaw, Warsaw 04-730, Poland,

    W. Grajkowska

  29. Division of Anatomical Pathology, Department of Pathology and Molecular Medicine, McMaster University, Hamilton General Hospital, Hamilton, Ontario L8S 4K1, Canada,

    B. Lach

  30. Department of Neuropathology Ruprecht-Karls-University Heidelberg, Institute of Pathology, Heidelberg 69120, Germany,

    A. von Deimling

  31. University of Michigan Cell and Developmental Biology, Ann Arbor, 48109-2200, Michigan, USA

    X. Fan & A. Korshunov

  32. Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, 48109, Michigan, USA

    X. Fan & K. M. Muraszko

  33. Department of Neurosurgery, University of California San Francisco, San Francisco, 94143-0112, California, USA

    N. Gupta

  34. Departments of Neurology, Pediatrics, and Neurosurgery, University of California, San Francisco, The Helen Diller Family Cancer Research Building, San Francisco, California 94158, USA,

    J. Phillips & W. A. Weiss

  35. Department of Neuro-oncology, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada,

    A. Huang, U. Tabori & E. Bouffet

  36. Department of Haematology and Oncology, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada,

    D. Malkin

  37. Departments of Pediatrics and Human Genetics, McGill University and the McGill University Health Center Research Institute, Montreal, Quebec H3Z 2Z3, Canada,

    N. Jabado

  38. Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1X8, Canada,

    M. Lupien

  39. Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada,

    P. B. Dirks

  40. CCU Neuropathology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany,

    A. Korshunov

Authors
  1. S. C. Mack
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Witt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. M. Piro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Zuyderduyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. M. Stütz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. X. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Gallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. L. Garzia
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. K. Zayne
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. X. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. V. Ramaswamy
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. N. Jäger
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. D. T. W. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. M. Sill
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. T. J. Pugh
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. M. Ryzhova
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. K. M. Wani
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. D. J. H. Shih
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. R. Head
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. M. Remke
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. S. D. Bailey
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. T. Zichner
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. C. C. Faria
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. M. Barszczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. S. Stark
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. H. Seker-Cin
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. S. Hutter
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. P. Johann
    View author publications

    You can also search for this author in PubMed Google Scholar

  30. S. Bender
    View author publications

    You can also search for this author in PubMed Google Scholar

  31. V. Hovestadt
    View author publications

    You can also search for this author in PubMed Google Scholar

  32. T. Tzaridis
    View author publications

    You can also search for this author in PubMed Google Scholar

  33. A. M. Dubuc
    View author publications

    You can also search for this author in PubMed Google Scholar

  34. P. A. Northcott
    View author publications

    You can also search for this author in PubMed Google Scholar

  35. J. Peacock
    View author publications

    You can also search for this author in PubMed Google Scholar

  36. K. C. Bertrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  37. S. Agnihotri
    View author publications

    You can also search for this author in PubMed Google Scholar

  38. F. M. G. Cavalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  39. I. Clarke
    View author publications

    You can also search for this author in PubMed Google Scholar

  40. K. Nethery-Brokx
    View author publications

    You can also search for this author in PubMed Google Scholar

  41. C. L. Creasy
    View author publications

    You can also search for this author in PubMed Google Scholar

  42. S. K. Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

  43. J. Koster
    View author publications

    You can also search for this author in PubMed Google Scholar

  44. X. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  45. Y. Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  46. T. Milde
    View author publications

    You can also search for this author in PubMed Google Scholar

  47. P. Sin-Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  48. J. Zuccaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  49. L. Lau
    View author publications

    You can also search for this author in PubMed Google Scholar

  50. S. Pereira
    View author publications

    You can also search for this author in PubMed Google Scholar

  51. P. Castelo-Branco
    View author publications

    You can also search for this author in PubMed Google Scholar

  52. M. Hirst
    View author publications

    You can also search for this author in PubMed Google Scholar

  53. M. A. Marra
    View author publications

    You can also search for this author in PubMed Google Scholar

  54. S. S. Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

  55. D. Fults
    View author publications

    You can also search for this author in PubMed Google Scholar

  56. L. Massimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  57. Y. J. Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  58. T. Van Meter
    View author publications

    You can also search for this author in PubMed Google Scholar

  59. W. Grajkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  60. B. Lach
    View author publications

    You can also search for this author in PubMed Google Scholar

  61. A. E. Kulozik
    View author publications

    You can also search for this author in PubMed Google Scholar

  62. A. von Deimling
    View author publications

    You can also search for this author in PubMed Google Scholar

  63. O. Witt
    View author publications

    You can also search for this author in PubMed Google Scholar

  64. S. W. Scherer
    View author publications

    You can also search for this author in PubMed Google Scholar

  65. X. Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  66. K. M. Muraszko
    View author publications

    You can also search for this author in PubMed Google Scholar

  67. M. Kool
    View author publications

    You can also search for this author in PubMed Google Scholar

  68. S. L. Pomeroy
    View author publications

    You can also search for this author in PubMed Google Scholar

  69. N. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  70. J. Phillips
    View author publications

    You can also search for this author in PubMed Google Scholar

  71. A. Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  72. U. Tabori
    View author publications

    You can also search for this author in PubMed Google Scholar

  73. C. Hawkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  74. D. Malkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  75. P. N. Kongkham
    View author publications

    You can also search for this author in PubMed Google Scholar

  76. W. A. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  77. N. Jabado
    View author publications

    You can also search for this author in PubMed Google Scholar

  78. J. T. Rutka
    View author publications

    You can also search for this author in PubMed Google Scholar

  79. E. Bouffet
    View author publications

    You can also search for this author in PubMed Google Scholar

  80. J. O. Korbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  81. M. Lupien
    View author publications

    You can also search for this author in PubMed Google Scholar

  82. K. D. Aldape
    View author publications

    You can also search for this author in PubMed Google Scholar

  83. G. D. Bader
    View author publications

    You can also search for this author in PubMed Google Scholar

  84. R. Eils
    View author publications

    You can also search for this author in PubMed Google Scholar

  85. P. Lichter
    View author publications

    You can also search for this author in PubMed Google Scholar

  86. P. B. Dirks
    View author publications

    You can also search for this author in PubMed Google Scholar

  87. S. M. Pfister
    View author publications

    You can also search for this author in PubMed Google Scholar

  88. A. Korshunov
    View author publications

    You can also search for this author in PubMed Google Scholar

  89. M. D. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S.C.M., H.W., M.D.T., A.K. and S.M.P. conceived and led the study. S.C.M. performed sample preparation, data acquisition and bioinformatic analysis related to DNA methylation, ChIP-seq and transcriptional profiling experiments. S.C.M. also performed western blot analysis and contributed to in vitro and in vivo experiments. H.W. led whole-genome sequencing, whole-exome sequencing and whole-genome bisulphite sequencing efforts, with analytical support from R.M.P., L. Gu., N. Jäger, D.T.W.J., S.S., S.H., T.Z., A.M.S., T.J.P., M.S., H.S.-C., T.T., V.H. and J.O.K. S.Z. and G.D.B. developed and applied pathway analysis methods for all data sets in this study. K.N.-B., M.G., L. Garzia, K.Z., X. Wang, M.B., S.B., P.J., X. Wu, K.C.B., T.M., J.Z., P.S.-C., C.C.F., P.C.-B., Y.Y. and S.A. performed in vitro, in vivo and molecular/biochemical experiments central to the project. DNA methylation and ChIP-seq bioinformatic analysis and experimental design were supported by X.Z., V.R., P.N.K., A.M.D., P.A.N., D.J.H.S., J.P., M. Remke, F.M.G.C., L.L., S.P., S.W.S., S.D.B., M.G., J.K., I.C., R.H. and P.B.D., developed and characterized ependymoma primary cultures, and assisted with in vitro and in vivo experiments. C.L.C. and S.K.V. developed the EZH2 compounds and provided inhibitors for experimentation. S.S.R., L.M., Y.J.C., T.V.M., W.G., B.L., M. Ryzhova, A.K., N.G., J.P., K.W. and K.D.A. provided patient samples and clinical details that made this study possible. M.H., M.A.M., M.L., D.F., A.E.K., A.v.D., O.W., D.M., X.F., K.M.M., M.K., S.L.P., E.B., W.A.W., A.H., U.T., C.H., J.T.R., N. Jabado, J.O.K., R.E., P.L., G.D.B., K.D.A., P.B.D. and S.M.P. provided valuable input regarding study design, data analysis and interpretation of results. M.D.T., S.C.M., H.W., A.K. and S.M.P. wrote the manuscript. M.D.T. and S.M.P. provided financial and technical infrastructure and oversaw the study. M.D.T. and A.K. are joint senior authors and project co-leaders.

Corresponding authors

Correspondence to A. Korshunov or M. D. Taylor.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Figures

This file contains Supplementary Figures 1-18. (PDF 9722 kb)

Supplementary Tables

This file contains Supplementary Tables 1-23. (XLSX 30536 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mack, S., Witt, H., Piro, R. et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature 506, 445–450 (2014). https://doi.org/10.1038/nature13108

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature13108

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing